Cargando…
Metabolic syndrome in hospitalized patients with chronic obstructive pulmonary disease
Introduction. The metabolic syndrome (MS) affects 21–53% of patients with chronic obstructive pulmonary disease (COPD) with a higher prevalence in the early stages of COPD, with results being highly variable between studies. MS may also affect natural course of COPD—number of exacerbations, quality...
Autores principales: | Mekov, Evgeni, Slavova, Yanina, Tsakova, Adelina, Genova, Marianka, Kostadinov, Dimitar, Minchev, Delcho, Marinova, Dora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493698/ https://www.ncbi.nlm.nih.gov/pubmed/26157632 http://dx.doi.org/10.7717/peerj.1068 |
Ejemplares similares
-
Vitamin D Deficiency and Insufficiency in Hospitalized COPD Patients
por: Mekov, Evgeni, et al.
Publicado: (2015) -
One-year mortality after severe COPD exacerbation in Bulgaria
por: Mekov, Evgeni, et al.
Publicado: (2016) -
MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs
por: Petkova, Veronika, et al.
Publicado: (2022) -
EGFR mutation status yield from bronchoalveolar lavage in patients with primary pulmonary adenocarcinoma compared to a venous blood sample and tissue biopsy
por: Yanev, Nikolay, et al.
Publicado: (2021) -
Diaphragmatic Movement at Rest and After Exertion: A Non-Invasive and Easy to Obtain Prognostic Marker in COPD
por: Mekov, Evgeni, et al.
Publicado: (2022)